Posts by: Patricia Silva PhD

Patricia Silva PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

February 16, 2016February 16, 2016

Increases in Bronchiectasis Cases, Disease Severity a Worrying Trend in New Zealand

News

Bronchiectasis is a growing health problem in New Zealand, with disease-related hospitalizations having risen by 30 percent between 2000 and 2013, and the number of annual deaths having more than doubled in ... Read more

February 2, 2016February 2, 2016

FDA Gives Nod to Start of Phase 1 Drug Trial for NTM Infections

News

Matinas BioPharma Holdings of Bedminster, N.J., recently announced that its investigational new drug (IND) application to the U.S. Food and Drug Administration is open and the company has been authorized to ... Read more

December 15, 2015December 15, 2015

Patient Registry for Primary Ciliary Dyskinesia Getting Underway

News

A recent study publicized the launch of the first international registry for patients with primary ciliary dyskinesia (PCD), a rare lung condition that can lead to bronchiectasis. The study, in the European Respiratory ... Read more

December 1, 2015December 1, 2015

Bronchiectasis Cases Rising Among Older People in the UK

News

A new study reported that an increasing number of people in the United Kingdom are being diagnosed with bronchiectasis, a lung disease long thought a thing of the past, with nearly 1% of ... Read more

November 24, 2015December 1, 2015

Aradigm’s Bronchiectasis Therapy Advancing in Phase 3 Studies

News

Aradigm Corporation, a pharmaceutical company dedicated to the prevention and treatment of severe pulmonary diseases, recently gave an update on its promising therapy Pulmaquin, now in fully enrolled clinical studies, and announced the ... Read more

November 17, 2015November 17, 2015

Gold Crest Care Center Offers Bronchiectasis Patients a Special Rehabilitation Program

News

The Gold Crest Care Center, a rehabilitation facility in Bronx, New York, recently announced the start of a Skilled Nursing Pulmonary Rehabilitation Program dedicated to the treatment of patients with ... Read more

November 5, 2015August 28, 2017

Non-Cystic Fibrosis Bronchiectasis Patients Successfully Treated with Inhaled Antibiotics

News

Researchers at the Medical University of South Carolina recently reported on the differences between patients with non-cystic fibrosis (CF) bronchiectasis treated with or without inhaled antibiotics, and showed that treatment ... Read more

October 29, 2015November 3, 2015

Bronchiectasis Patients May Benefit from Mechanical Insufflation-Exsufflation

News

A study recently presented at the CHEST Annual Meeting 2015 in Montreal, Canada (Oct. 24–28), revealed a case report suggesting that mechanical insufflation-exsufflation (MI-E) may be beneficial for patients with ... Read more

October 27, 2015October 27, 2015

PCORI Funds $83 Million for Patient-Centered Studies on Several Conditions Including Bronchiectasis

News

Patient-Centered Outcomes Research Institute (PCORI) is a non-profit organization that funds research with the goal of obtaining evidence-based information that helps patients, caregivers and clinicians make better-informed healthcare decisions. The ... Read more

October 22, 2015October 22, 2015

Raptor Pharmaceutical Acquires Quinsair, a Potential Therapeutic for Bronchiectasis

News

Raptor Pharmaceutical Corp., a biopharmaceutical company focused on therapeutics for rare, debilitating diseases, recently reported that it has acquired exclusive global rights and assets to develop, manufacture and commercialize Quinsair™ ... Read more